John White and Ting Chen Speak at the 38th Annual Federal Securities Institute
February 14, 2020
Cravath partners John W. White and Ting S. Chen spoke at the 38th Annual Federal Securities Institute, hosted by the Business Law Section of the Florida Bar in Coral Gables, Florida from February 13‑14, 2020.
John co-chaired the conference and moderated a panel entitled “Accounting in 2020: What Lawyers Should Focus On.” Ting spoke on the “Public Company M&A Deals” panel.
The conference brought together corporate, M&A and securities practitioners, in‑house counsel, executives and advisors to discuss structuring acquisitions and capital‑raising transactions, navigating regulatory enforcement issues, corporate governance and cybersecurity.
Related Practices & Industries
Speakers
- Photo
-
-
J.D., 1973, New York University School of LawOrder of the Coif, cum laude
-
B.S., 1970, University of Virginiawith Honors
- New York
Education
Admitted In
- Photo
-
-
J.D., 2006, Stanford Law School
-
A.B., 2003, Harvard CollegePhi Beta Kappa, summa cum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
Akorn Reaches Settlement with the SEC Following Investigation into Accounting Restatements
On March 26, 2018, Cravath client Akorn, Inc. (“Akorn”), a U.S.-based manufacturer and marketer of prescription and over-the-counter pharmaceutical products, reached a settlement in a civil action brought by the Securities and Exchange Commission (“SEC”) in the United States District Court for the Northern District of Illinois. The complaint alleged financial reporting, books and records, and internal accounting controls violations in connection with Akorn’s accounting restatements for the fiscal year 2014. Akorn cooperated with the SEC and, pursuant to the settlement, did not admit or deny the SEC's allegations or pay any financial sanction.
Deals & Cases
November 01, 2019
Roivant and Sumitomo Dainippon Pharma’s Strategic Alliance
On October 31, 2019, Roivant Sciences Ltd. (“Roivant”), a technology‑enabled healthcare company, and Sumitomo Dainippon Pharma Co., Ltd. (“Sumitimo Dainippon Pharma”), a leading Japanese pharmaceutical company, announced they have signed a definitive agreement for the creation of a novel and broad strategic alliance to form a new company owned and supported by Sumitomo Dainippon Pharma.
Deals & Cases
November 25, 2019
Schwab’s $26 Billion Acquisition of TD Ameritrade
On November 25, 2019, The Charles Schwab Corporation (“Schwab”) and TD Ameritrade Holding Corporation (“TD Ameritrade”) announced that they have entered into a definitive agreement for Schwab to acquire TD Ameritrade in an all‑stock transaction valued at approximately $26 billion. Cravath is representing the Ricketts family in connection with the transaction.
